The new findings should help public health officials more quickly and accurately determine which strains to include in the annual flu vaccine.
The study, supported in part by the National Institutes of Health (NIH), appears online in advance of print in the journal Nature.
The researchers analyzed full gene sequences of seasonal influenza virus samples collected from the world’s temperate regions north and south of the equator. Their data comprised full genetic sequences of 1,302 isolates of influenza A virus collected over 12 years from New Zealand and New York state.
By quantifying the degree of genetic diversity among the strains’ subtypes, gene segments and geographic locations, the researchers were able to detect patterns indicating that virus strains do not persist from one flu season to the next in the temperate regions. Therefore, the researchers deduced, new flu strains emerge annually from the tropics.
The international team of researchers included Jeffery K. Taubenberger, M.D., Ph.D., of the National Institute of Allergy and Infectious Diseases, NIH; Cecile Viboud, Ph.D., of NIH’s Fogarty International Center; and Edward C. Holmes, Ph.D., of Pennsylvania State University, who received funding from the National Institute of General Medical Sciences, NIH. The gene sequence information is stored in an NIAID-supported and publicly accessible database, the Influenza Genome Sequencing Project http://www3.niaid.nih.gov/research/resources/mscs/Influenza/.
ARTICLE: A Rambaut et al. The genomic and epidemiological dynamics of human influenza A virus. Nature DOI: 10.1038/nature06945 (2008).
WHO: NIAID Director Anthony S. Fauci, M.D., is available to comment. Jeffery K. Taubenberger, M.D., Ph.D., Laboratory of Infectious Diseases, NIAID, is also available.
CONTACT: To schedule interviews, contact Anne A. Oplinger in the NIAID Office of Communications and Government Relations at 301-402-1663 or email@example.com.
NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.
The National Institutes of Health (NIH)--The Nation's Medical Research Agency--includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases.
News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf
First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology